{"name":"Impact Therapeutics, Inc.","slug":"impact-therapeutics-inc","ticker":"","exchange":"","domain":"impact.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"14C-IMP4297","genericName":"14C-IMP4297","slug":"14c-imp4297","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"IMP4927","genericName":"IMP4927","slug":"imp4927","indication":"Advanced solid tumors (in combination with checkpoint inhibitors)","status":"phase_3"}]}],"pipeline":[{"name":"14C-IMP4297","genericName":"14C-IMP4297","slug":"14c-imp4297","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IMP4927","genericName":"IMP4927","slug":"imp4927","phase":"phase_3","mechanism":"IMP4927 is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) that reduces macrophage infiltration and activation in the tumor microenvironment.","indications":["Advanced solid tumors (in combination with checkpoint inhibitors)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNWGhJNzlqZjFKeTVGbEdxcG9aRWdJZTFkY01MOS1ZYTZ4ZlFKVWFaVlViMHJVazVkc1VFX1YtRWh1UVBoa0g5N2JhTzR4TGw5eW8zU0lMdURrODYzUFBMX3AzSVltcUVXSlZEb3NQOEFsenlNNkhWVDQ0SmQ5MF9qU3dHc1pybmF0Z0lMY0Qyb1B4UQ?oc=5","date":"2026-03-30","type":"regulatory","source":"富途牛牛","summary":"IPO News | Impella Pharma’s Hong Kong IPO and the ‘full circulation’ of unlisted domestic shares have been filed with the China Securities Regulatory Commission. - 富途牛牛","headline":"IPO News | Impella Pharma’s Hong Kong IPO and the ‘full circulation’ of unlisted domestic shares have been filed with th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSjVzUUZ0MEg2OVcxWnlpbkQ5c3pZVC1DenE3ZXZzTUgxNHFSVVhMb294NkVkMmpiMU9fNEtyaXhGQU9ROE9EQ2hNWDlfQTFySEtSdjV4LXkwMi0wZ0tfN0l2endvSEJxYWxLajV4cVVMRVJ0bW9MQWtCdUJ0eEo3dXZuNVZBMmF1T0RTQ1EzVlVKUWoxM2c?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034 - Fortune Business Insights","headline":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOZmVlSjN0VHo3N3NTdUFodW5Kb3kyV1l5dWt1YzBrYWlnUzZaRm9DY093aXFoZE5MQmxuVXRDbDFSSGZRYmx5aEhDRlByQXBET0JmX0tTZ0IxUEJzd1lLSjRzWGVxZkNtbGh6RUduLThjYU0wQW4yS282NXpMOG1LanZiZ1BYS2cxbVJHQw?oc=5","date":"2026-02-17","type":"pipeline","source":"Yahoo Finance","summary":"John Paulson's Strategic Moves: Madrigal Pharmaceuticals Inc. Sees a -3.09% Impact - Yahoo Finance","headline":"John Paulson's Strategic Moves: Madrigal Pharmaceuticals Inc. Sees a -3.09% Impact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPVGEyVnBISmFjd0M2MjlkTFhqZTdMdVhlbDZSMU9tTnlObkg5QXVtY0ttOGVaZU1ja0ZKOU1tNF8xRUVzY3lYUHpsOG9kRTdBM1RaR2V1OTh4dGxka2NJMlBvQUZ6SEp0dEhlalNaZnlUaUlqQmI2UFotR0JqdllGZHk3azVPWks1cWxsWWo5NWJ1cGpzbjg4dk82Rl95RHJQSUtsQzZR?oc=5","date":"2026-02-05","type":"pipeline","source":"Fierce Biotech","summary":"Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024 - Fierce Biotech","headline":"Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPUnl4SFdmMjZsRFRiR3lvaHRNUjZuX3NiSjlleTdXdHd2TFFOY0hiVXliSFR6Y0JxaTRxWloyY0FsR1dnQTFzWHM5dGxVcHJGLVlpME1VOFFxTTlUU1hZc2V6RVJHUmR3QjZSdWRmTWRKVDZEbkZhaDg0TkJjQTlGZFUxMkVHMUdkazhQNjEwWQ?oc=5","date":"2026-01-28","type":"pipeline","source":"Fierce Biotech","summary":"Eikon sets $274M goal for upcoming stock market debut - Fierce Biotech","headline":"Eikon sets $274M goal for upcoming stock market debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOUXpkX0syamF1amVTajdnMHJDdWV0T0gxLUR5aTBVNVRraW1DSVBLVHFNRGhnSkl6N1F3eGdXNGYxWjhPTzZEV0lwUDRxY1Q4bkdpTUZIN1ZJNGpSYm8yV1hCUVNCSzVMU1ctVXhVQVlpOHpBMlF2N3pJVUJaUERXMFpweTFwcHBZUDdHUWlIV0N0RGR3cEI5UkdtaDk4SG1aT2Vka2ZYbXZwa3JHV3Aya05QMEg5YjZKTENtdGFvMA?oc=5","date":"2026-01-20","type":"pipeline","source":"Hinrich Foundation","summary":"How US tariffs impact global pharmaceutical trade and patients | White paper - Hinrich Foundation","headline":"How US tariffs impact global pharmaceutical trade and patients | White paper","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQU3ZzT3hRN3h6RUZTVGRPd2tzMkxfYkpfZ1JST1gtc3c4TGRhOFRNNG9fcUd3Y0pIeXp3RTZ2dW5fM082X3ZUM3RzUzZTT1ZkRlNqaUtWcmhKVXg1aWdpVHl0LW1MMVI2d0cyMm9JMjFtSXJnMmdsS2tPUXdYWEJpX3JNaXJMc3JvQUVsc3AzUU53LWxT?oc=5","date":"2026-01-11","type":"pipeline","source":"BioPharma Dive","summary":"Eikon, a high-profile startup led by Merck vets, seeks an IPO - BioPharma Dive","headline":"Eikon, a high-profile startup led by Merck vets, seeks an IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNUG5oNlRuTHZpdDZYTE4xb2d0dkJqVkx4bHBvc1hCS3V6RmU4OWFSXzdqUWlLWTkwd0NXdjREVnpjV2RWc1Iwd09pMXhxeHFNY2NHVUJETk10b1VtQVh2Q2hTUUJoY0FuN1JCRW5tenQ4RGRMRkpCYkdmWTNBajY5cVVYMWd2RV9jeWc?oc=5","date":"2025-12-08","type":"pipeline","source":"StocksToTrade","summary":"Arrowhead Pharmaceuticals Flourishes with Key Milestones and Growth Projections - StocksToTrade","headline":"Arrowhead Pharmaceuticals Flourishes with Key Milestones and Growth Projections","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQOFNNdWw3MnhVbHFlUzJzWVQyZExuTW5ncVVqN0VGclhONkp4am9HVjg0Yk9wTlhmWkwxYXQxcTUwQWZyd3hlSmt5UHFkei1yNllPbEdFTnpIcWFFYWxHeE8xdEtMemVFOGd3b1ZyVXMzNnZKYjZTRGNKMXJEX1J2Q2pDcw?oc=5","date":"2025-11-26","type":"trial","source":"Yahoo Finance","summary":"How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors - Yahoo Finance","headline":"How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOcjUwNU5aTjg3a0xlcTY4OHZaYWlueDlueGhfWnR2UXlHTHZZM2lrSF9oOFJqMUdGM0hKRlRyS2tFMUk1NWk2aVJ1blBDVUVvVlBsY2ZKXzhKVDYwYlJqdlVLSm15RkFudFVub2lqdVI1WTRjNExDdm1QbDJ0Y1JCa0llb1JIX1FHQTZwdktJWS1nT00wUmpkeDJwd2MzR0RsSWFGaDVla3dYUjhyd2Z2UGFINTI?oc=5","date":"2025-09-26","type":"pipeline","source":"PharmTech.com","summary":"How 100% Pharmaceutical Tariffs Will Impact Domestic Manufacturing and Supply Chains - PharmTech.com","headline":"How 100% Pharmaceutical Tariffs Will Impact Domestic Manufacturing and Supply Chains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNQlFMSDZVOU5QbUI1VF95dWFRTmZXeVRuQ0huU1MyY2NPaWZFSFV0Nk4xTUpGNWNYLUxxdThUbUVUVXJ5NlRwRDdfeU85aFppWmN6NDFnLUNCYlZnWnRzQWlENVFEX2k0dm1PaUJveHYtX1BLcjFveFExcnhqMWQ2c3hhaWliblQ2WmpZWnRkUDl5MnRiUW1fcnBXcGpLQkxCTFRzclVaVXRvT3E5NHFVWU5SN1RReFNVd0otbUhQUlg5c0ZmR0hWNUVRakpWa2pOMmgxRGgwQURnSGw2azkzYTRQcUZZdWRoVXcwS3NYY2FDcUhyc2x3SzVkaGFOWkRUTVQ3dmpVbWpsd0RWWFVwRkhB?oc=5","date":"2025-09-04","type":"pipeline","source":"PR Newswire","summary":"Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development - PR Newswire","headline":"Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Dru","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPWF92a2ZxVFVPR0x1V0lkOFpEOThmZXFOWXJvZEltd0JKUWxmdl9HSngzYmw1NzFXM080WDBzZEtIN1I1SFlYWEhoQWJyaTZsaGlsTmtuYW5wU1FfNkRENXF5NTRZQXlST2xrclhkMS1CN1pnNmJEYmQyekVnbWRTLUhZMnZjaGY4ZXNjNHZmS21nUTB2THdlX3B6Z01XSjZRbXVjMVNPcWJZakF2YWN3LXBjWkV1d2RqVl9URk02MTgweDVaSk13bTMwZXZMYmk5dnFNUUVBN2ZYR0xEejVpeXhmQkJudw?oc=5","date":"2025-04-16","type":"deal","source":"citybiz","summary":"Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Robert S. Langer To Scientific Advisory Board - citybiz","headline":"Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Robert S. Langer To Scientific Advisory Board","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}